GlassScriptPhysician profile
Nicholas Garrett Watson
NPI 1295116606
$970.83
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $323 · 2020: $59.04 · 2021: $23.47 · 2022: $434 · 2023: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $131.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $218.33 | 2019-2023 | Freestyle Libre 3 |
| Baxter Healthcare | $192.62 | 2022 | |
| Janssen Pharmaceuticals, INC | $98.15 | 2019-2022 | |
| Pfizer INC. | $68.92 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $58.18 | 2019-2022 | |
| Abbvie INC. | $45.44 | 2023 | Vraylar, Ubrelvy |
| Amgen INC. | $43.62 | 2019-2023 | Prolia, Evenity |
| Astrazeneca Pharmaceuticals LP | $36.30 | 2019-2023 | Farxiga |
| Takeda Pharmaceuticals U.S.A., INC. | $36.07 | 2019 | |
| Bausch Health US, LLC | $18.54 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.08 | 2022 | |
| Lilly USA, LLC | $14.93 | 2022 | |
| Ironwood Pharmaceuticals, INC | $14.47 | 2019 | |
| Novo Nordisk INC | $13.16 | 2022 | |
| Edwards Lifesciences Corporation | $13.06 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $12.16 | 2020 | |
| Amarin Pharma, INC. | $12.12 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.97 | 2019 | |
| Genentech USA, INC. | $11.83 | 2019 | |
| Gilead Sciences, INC. | $11.81 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.62 | 2019 | |
| Glaxosmithkline, LLC. | $11.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.